⌘K

Login Start Free

Home/Filings/4/0001415889-25-006675

4//SEC Filing

Miller Aine 4

Accession 0001415889-25-006675

CIK 0001583107other

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 6:09 PM ET

Size

4.6 KB

Accession

0001415889-25-006675

Insider Transaction Report

Form 4

Period: 2025-02-28

Theravance Biopharma, Inc.TBPH

SVP, DEV & HEAD OF IRE OFFICE

Transactions

Award
Ordinary Shares
2025-02-28+75,000→ 214,261 total

Documents

1 file

4
form4-03042025_110312.xmlPrimary

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1

filerCIK 0002012524

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 6:09 PM ET
Size: 4.6 KB

View on SEC.gov